NCT05587569View on ClinicalTrials.gov

Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 28, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2030

Conditions
Metatarsus AdductusHallux Valgus
Interventions
DEVICE

Treatment of metatarsus adductus and hallux valgus with the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure

Patients 14 years of age or older with symptomatic metatarsus adductus and hallux valgus will be eligible to participate based on the inclusion/exclusion criteria established in the study protocol. Anticipated study duration will be 5 years post index procedure.

Trial Locations (9)

15090

RECRUITING

Greater Pittsburgh Foot and Ankle Center, Wexford

27560

RECRUITING

Duke Orthopaedics Arringdon, Morrisville

44224

RECRUITING

Ohio Foot and Ankle Center, Stow

44708

RECRUITING

Ohio Foot and Ankle Center, Canton

50023

RECRUITING

Foot and Ankle Center of Iowa, Ankeny

65019

RECRUITING

JCMG - Jefferson City Medical Group, Jefferson City

76248

RECRUITING

Foot and Ankle Associates of North Texas - Keller, Keller

80634

RECRUITING

Foot and Ankle Center of the Rockies, Greeley

04096

RECRUITING

Coastal Maine Foot and Ankle, Yarmouth

All Listed Sponsors
lead

Treace Medical Concepts, Inc.

INDUSTRY